Figure.

The sickle-cell disease super-utilizer protocol was designed to expedite analgesic administration and reduce redundant laboratory tests and imaging for patients meeting inclusion criteria. If patients are determined to be clinically stable by the provider with appropriate vital signs, the patient’s treatment plan developed by the multidisciplinary team can be implemented, thereby expediting and standardizing care. If the patient has been evaluated by laboratory examination or radiographs in the ED or clinic within five days of their current ED visit, the provider can defer work-up at that time and implement the patient’s treatment plan, serving to reduce redundant work-up and further expedite and standardize care. If a hematologic emergency is suspected, a comprehensive evaluation is warranted based on provider discretion.

ED, emergency department; VOE, vaso-occlusive event.